Tone at the top really does matter

The Man From FCPA Tom Fox looks at the case of disgraced pharmaceutical company Valeant and what new Chief Financial Officer Paul Herendeen has planned for the company’s future.

WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE

If you are already a registered user or a member, SIGN IN now.